companydata.dkCAND.PHARM. POVL M. ASSENS FOND: Financial statements 2020
CVR: 14536604
CAND.PHARM. POVL M. ASSENS FOND (CVR 14536604) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 0 and a net result of DKK 145,131 compared with DKK 4,924,086 the year before. Equity amounted to DKK 101,235,485. The solvency ratio was 97.3%. The company had 37 employees in the financial year.
- Revenue
- 0 kr.
- Gross Profit
- 0 kr.
- Profit/Loss
- 145,131 kr.
- Equity
- 101,235,485 kr.
- Total Assets
- 104,005,041 kr.
- Employees
- 37
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | 0 | 145 t. | 101.2 mio. | 37 |
| 2019 | 0 | 0 | 4.9 mio. | 102.9 mio. | 36 |
| 2018 | 0 | 0 | -1.7 mio. | 98.9 mio. | 36 |
| 2017 | 0 | 0 | 5.2 mio. | 101.6 mio. | 32 |
| 2016 | 0 | 0 | 5.1 mio. | 97.2 mio. | 29 |
How creditworthy is CAND.PHARM. POVL M. ASSENS FOND?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of August 14, 2020, Tyge Jesper Rothe has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 14, 2020, Søren Wang Petersen has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 14, 2020, Ole Kondrup has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 13, 2020, Tyge Jesper Rothe has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 4,924,086.
About CAND.PHARM. POVL M. ASSENS FOND
CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000.